Non-Hodgkin-Lymphon
NHL: Zuma I
A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of KTE-C19 in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1).Read More
NHL: Blinatumumab 20140286
A Phase 1b Open-label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma.Read More
NHL: JCAR17-BCM-001
A phase 2, single-arm, multicohort, multicentral trial to determine the efficiancy and safety of JCAR017 in adult subjects with aggressive B-Cell non-hodgkin lymphoma.Read More
NHL: CJBH492A12101
A phase I/Ib open-label, multi-center dose escalation study of JBH492 in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) and Non-Hodgkin´s Lymphoma (NHL).Read More